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Case {#ccr3440-sec-0001}
====

A 60‐year‐old male patient referred to the clinic presented with painful swelling of both great toes. He was diagnosed as having gout four years ago, and was suffering from waxing and waning symptoms in spite of treatment with allopurinol. He had no comorbid conditions. During the last month, the lesions became markedly swollen, which were not subsided by conservative management and were complicated with ulcerated mass and whitish discharge (Fig. [1](#ccr3440-fig-0001){ref-type="fig"}A and B). Polarized microscope revealed a deposition of monosodium urate crystals with negative birefringence (Fig. [1](#ccr3440-fig-0001){ref-type="fig"}C). We detected giant gouty tophi in both great toes and multiple tophi around medial and lateral malleoli by three‐dimensional dual‐energy computed tomography (3D DECT) (Fig. [2](#ccr3440-fig-0002){ref-type="fig"}A). The initial concentration of uric acid was 8.3 mg/dL. Surgical excision and curettage of tophi in the great toes were performed to remove a source of infection and to prevent functional impairment. He continued to be treated with lifestyle adjustment and intensified urate‐lowering agent of allopurinol 300 mg daily, and uric acid level was maintained below 6 mg/dL. Transiently, prednisolone 10 mg and colchicine 1T were given to the patient. During follow‐up visits for 1 year, there was no episode of gout attack. Final uric acid was 4.5 mg/dL. Follow‐up 3D DECT at eight months after treatment showed elimination of urate deposition in the great toes as well as in other lesions (Fig. [2](#ccr3440-fig-0002){ref-type="fig"}B).

![Swollen toe and MSU crystals. (A) Photograph of tophaceous toe. (B) Aspirate of tophi was white fluid. (C) Polarized microscope. Monosodium urate crystals with negative birefringence.](CCR3-4-097-g001){#ccr3440-fig-0001}

![DECT revealed multiple tophi. (A) Initial DECT. Giant gouty tophi in both great toes and multiple tophi around medial and lateral malleoli. (B) Follow‐up 3D DECT at eight months after treatment.](CCR3-4-097-g002){#ccr3440-fig-0002}

Discussion {#ccr3440-sec-0002}
==========

Gout remains a diagnosis and treatment challenge for both acute and chronic disease. Diagnosis of gout is confirmed by polarized microscope revealing a deposition of monosodium urate crystals (MSU) with negative birefringence. In real clinic, it is frequently not feasible to obtain MSC crystal. Needle puncture, risk of cellulitis, and bleeding tendency are barriers to access direct visualization of MSU crystal in gout‐suspected patients. Furthermore, it is impossible to get samples at deep‐seated places such as atlantoaxial joint, Achilles tendon, and so on. However, DECT also can detect MSU crystal without need of a joint puncture. Therefore, DECT is now regarded as the new promising diagnostic tool in gout diagnosis. Acute gouty attack is usually alleviated by intensive treatment such as nonsteroidal anti‐inflammatory drug and steroid. Even in patients with chronic tophaceous gout, active treatment with pharmacologic and nonpharmacologic modalities can dissolute the MSU crystals, and thus reduce urate volumes. DECT utilization can be used for assessing the therapeutic outcome.
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